Results 1 to 10 of about 7,666 (128)

Acellular Pertussis Vaccine Components: Today and Tomorrow [PDF]

Vaccines, 2020
Pertussis is a highly communicable acute respiratory infection caused by Bordetella pertussis. Immunity is not lifelong after natural infection or vaccination. Pertussis outbreaks occur cyclically worldwide and effective vaccination strategies are needed
Kalyan K Dewan, Bodo Linz, Eric T Harvill   +2 more
exaly   +3 more sources

Evaluation of acellular pertussis vaccine: comparisons among different strains of mice. [PDF]

Emerg Microbes Infect, 2023
Wei J, Guang J, Wei C, Wang H, Zhou J, Li H, Wang L, Ma X, Yue B.   +8 more
europepmc   +1 more source

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants. [PDF]

Emerg Microbes Infect, 2023
Knuutila A, Barkoff AM, Ivaska L, Tenhu E, Teräsjärvi J, van Gageldonk P, Buisman A, Mertsola J, He Q, PERISCOPE consortium.   +9 more
europepmc   +1 more source

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy. [PDF]

Med Princ Pract, 2022
Alghounaim M, Alsaffar Z, Alfraij A, Bin-Hasan S, Hussain E.   +4 more
europepmc   +1 more source

Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model. [PDF]

Vaccines (Basel), 2023
Yang B, Zhu D, Zhou Y, Gong B, Hu Y, Zhang J, Huang S, Nian X, Li X, Li X, Duan K, Yang X.   +11 more
europepmc   +1 more source

Estimating Population-Level Effects of the Acellular Pertussis Vaccine Using Routinely Collected Immunization Data. [PDF]

Clin Infect Dis, 2021
Rane MS, Halloran ME.
europepmc   +1 more source

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine. [PDF]

J Infect Dis, 2022
Peterson JT, Zareba AM, Fitz-Patrick D, Essink BJ, Scott DA, Swanson KA, Chelani D, Radley D, Cooper D, Jansen KU, Dormitzer PR, Gruber WC, Gurtman A.   +12 more
europepmc   +1 more source

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization. [PDF]

Front Immunol, 2023
Yount KS, Hall JM, Caution K, Shamseldin MM, Guo M, Marion K, Fullen AR, Huang Y, Maynard JA, Quataert SA, Deora R, Dubey P.   +11 more
europepmc   +1 more source

How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile? [PDF]

Hum Vaccin Immunother, 2021
Aguirre-Boza F, San Martín P P, Valenzuela B MT.   +2 more
europepmc   +1 more source

Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against Bordetella pertussis in a Mouse Model. [PDF]

Front Immunol, 2022
Jiang W, Wang X, Su Y, Cai L, Li J, Liang J, Gu Q, Sun M, Shi L.   +8 more
europepmc   +1 more source